A new kind of drug, a Raf kinase inhibitor, is well-tolerated and may prove effective in treating patients with metastatic melanoma, according to researchers from the Abramson Cancer Center of the University of Pennsylvania.
Combination Treatments in HS Require Further Review
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Native American and Indigenous Communities Face Dermatologic Barriers to Care, Disparities, and More
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Microwave Therapy Successful for Treating Warts in Children
CALL FOR INSIGHTS: Seeking Challenging Cases, Lingering Questions, & More for AD Awareness Month
2 Clarke Drive Cranbury, NJ 08512